Complement activation by recombinant HIV-1 glycoprotein gp120

The mechanism of CD4+ cell depletion in HIV-infected patients is poorly understood. In this study we investigated whether rgp120 can activate the complement system in the absence of anti-gp120 Abs. We found that the complement proteins C4, C3d, C5b-9, and properdin bind to rgp 120-coated CD4+ T cell...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Süsal, Caner (VerfasserIn) , Kirschfink, Michael (VerfasserIn) , Kröpelin, M. (VerfasserIn) , Daniel, Volker (VerfasserIn) , Opelz, Gerhard (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1994
In: The journal of immunology
Year: 1994, Jahrgang: 152, Heft: 12, Pages: 6028-6034
ISSN:1550-6606
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://www.jimmunol.org/content/152/12/6028
Volltext
Verfasserangaben:C. Süsal, M. Kirschfink, M. Kröpelin, V. Daniel, and G. Opelz

MARC

LEADER 00000caa a2200000 c 4500
001 1760586684
003 DE-627
005 20230428014439.0
007 cr uuu---uuuuu
008 210616s1994 xx |||||o 00| ||eng c
035 |a (DE-627)1760586684 
035 |a (DE-599)KXP1760586684 
035 |a (OCoLC)1341416527 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Süsal, Caner  |e VerfasserIn  |0 (DE-588)102648037X  |0 (DE-627)726772763  |0 (DE-576)37182673X  |4 aut 
245 1 0 |a Complement activation by recombinant HIV-1 glycoprotein gp120  |c C. Süsal, M. Kirschfink, M. Kröpelin, V. Daniel, and G. Opelz 
264 1 |c 1994 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.06.2021 
520 |a The mechanism of CD4+ cell depletion in HIV-infected patients is poorly understood. In this study we investigated whether rgp120 can activate the complement system in the absence of anti-gp120 Abs. We found that the complement proteins C4, C3d, C5b-9, and properdin bind to rgp 120-coated CD4+ T cells of healthy individuals when incubated in autologous serum. Activation of the complement system occurred primarily via the classical pathway and was abolished in sera deficient in C1q and C4 as well as in the presence of EDTA. No cell lysis was observed in a lymphocytotoxicity assay using human serum, possibly because of homologous restriction of complement lysis. In contrast, addition of rabbit sera induced lysis of the rgp 120-precoated cells. Cell lysis by rabbit serum was found to be because of naturally occurring IgM anti-gp 120 Abs. The rgp 120, which was immobilized on the surface of microtiter plates activated complement in the absence of lymphocytes. Complement activation by cell-bound HIV-1 envelope glycoprotein gp120 with subsequent opsonization may be relevant for the elimination of noninfected CD4+ T cells in HIV-infected patients. 
650 4 |a Amino Acid Sequence 
650 4 |a Animals 
650 4 |a CD4-Positive T-Lymphocytes 
650 4 |a Complement Activation 
650 4 |a Cytotoxicity, Immunologic 
650 4 |a Guinea Pigs 
650 4 |a HIV Envelope Protein gp120 
650 4 |a HIV Infections 
650 4 |a HIV-1 
650 4 |a Humans 
650 4 |a In Vitro Techniques 
650 4 |a Molecular Sequence Data 
650 4 |a Rabbits 
650 4 |a Rats 
650 4 |a Recombinant Proteins 
700 1 |a Kirschfink, Michael  |e VerfasserIn  |0 (DE-588)120927152  |0 (DE-627)080974457  |0 (DE-576)292452411  |4 aut 
700 1 |a Kröpelin, M.  |e VerfasserIn  |4 aut 
700 1 |a Daniel, Volker  |e VerfasserIn  |0 (DE-588)1058939513  |0 (DE-627)79784418X  |0 (DE-576)166309168  |4 aut 
700 1 |a Opelz, Gerhard  |d 1944-  |e VerfasserIn  |0 (DE-588)1026480345  |0 (DE-627)726772453  |0 (DE-576)371826527  |4 aut 
773 0 8 |i Enthalten in  |t The journal of immunology  |d Rockville, Md. : American Association of Immunologists, 1916  |g 152(1994), 12, Seite 6028-6034  |h Online-Ressource  |w (DE-627)269535217  |w (DE-600)1475085-5  |w (DE-576)079963838  |x 1550-6606  |7 nnas  |a Complement activation by recombinant HIV-1 glycoprotein gp120 
773 1 8 |g volume:152  |g year:1994  |g number:12  |g pages:6028-6034  |g extent:7  |a Complement activation by recombinant HIV-1 glycoprotein gp120 
856 4 0 |u https://www.jimmunol.org/content/152/12/6028  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210616 
993 |a Article 
994 |a 1994 
998 |g 1026480345  |a Opelz, Gerhard  |m 1026480345:Opelz, Gerhard  |d 910000  |d 911600  |e 910000PO1026480345  |e 911600PO1026480345  |k 0/910000/  |k 1/910000/911600/  |p 5  |y j 
998 |g 1058939513  |a Daniel, Volker  |m 1058939513:Daniel, Volker  |d 910000  |d 911600  |e 910000PD1058939513  |e 911600PD1058939513  |k 0/910000/  |k 1/910000/911600/  |p 4 
998 |g 120927152  |a Kirschfink, Michael  |m 120927152:Kirschfink, Michael  |d 910000  |d 911600  |e 910000PK120927152  |e 911600PK120927152  |k 0/910000/  |k 1/910000/911600/  |p 2 
998 |g 102648037X  |a Süsal, Caner  |m 102648037X:Süsal, Caner  |d 910000  |d 911600  |e 910000PS102648037X  |e 911600PS102648037X  |k 0/910000/  |k 1/910000/911600/  |p 1  |x j 
999 |a KXP-PPN1760586684  |e 3938815949 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Süsal, Caner","roleDisplay":"VerfasserIn","role":"aut","family":"Süsal","given":"Caner"},{"role":"aut","display":"Kirschfink, Michael","roleDisplay":"VerfasserIn","given":"Michael","family":"Kirschfink"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Kröpelin, M.","given":"M.","family":"Kröpelin"},{"family":"Daniel","given":"Volker","display":"Daniel, Volker","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Opelz, Gerhard","roleDisplay":"VerfasserIn","given":"Gerhard","family":"Opelz"}],"title":[{"title_sort":"Complement activation by recombinant HIV-1 glycoprotein gp120","title":"Complement activation by recombinant HIV-1 glycoprotein gp120"}],"note":["Gesehen am 16.06.2021"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1760586684","name":{"displayForm":["C. Süsal, M. Kirschfink, M. Kröpelin, V. Daniel, and G. Opelz"]},"origin":[{"dateIssuedDisp":"1994","dateIssuedKey":"1994"}],"id":{"eki":["1760586684"]},"physDesc":[{"extent":"7 S."}],"relHost":[{"title":[{"title_sort":"journal of immunology","title":"The journal of immunology"}],"pubHistory":["1.1916 -"],"part":{"pages":"6028-6034","issue":"12","year":"1994","extent":"7","volume":"152","text":"152(1994), 12, Seite 6028-6034"},"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Complement activation by recombinant HIV-1 glycoprotein gp120The journal of immunology","note":["Gesehen am 18.08.2025"],"corporate":[{"role":"isb","display":"American Association of Immunologists","roleDisplay":"Herausgebendes Organ"}],"language":["eng"],"recId":"269535217","origin":[{"publisherPlace":"Oxford ; Bethesda, Md. ; Rockville, Md.","dateIssuedKey":"2025","publisher":"Oxford University Press ; Soc. ; American Association of Immunologists","dateIssuedDisp":"2025-"}],"id":{"issn":["1550-6606"],"zdb":["1475085-5"],"eki":["269535217"]},"name":{"displayForm":["American Association of Immunologists"]},"physDesc":[{"extent":"Online-Ressource"}]}]} 
SRT |a SUESALCANECOMPLEMENT1994